Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
C. B. Eap, G. Gründer, P. Baumann, N. Ansermot, A. Conca, E. Corruble, S. Crettol, M. L. Dahl, J. de Leon, C. Greiner, O. Howes, E. Kim, R. Lanzenberger, J. H. Meyer, R. Moessner, H. Mulder, D. J. Müller, M. Reis, P. Riederer, H. G. Ruhe, O. Spigset, E. Spina, B. Stegman, W. Steimer, J. Stingl, S. Suzen, H. Uchida, S. Unterecker, F. Vandenberghe & C. Hiemke. (2021) Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants. The World Journal of Biological Psychiatry 22:8, pages 561-628.
Read now
Read now
Alfredo Carlo Altamura, Alice Caldiroli & Massimiliano Buoli. (2015) Pharmacokinetic evaluation of fluvoxamine for the treatment of anxiety disorders. Expert Opinion on Drug Metabolism & Toxicology 11:4, pages 649-660.
Read now
Read now
Articles from other publishers (16)
Khairulanwar Burhanuddin & Raj Badhan. (2022) Optimising Fluvoxamine Maternal/Fetal Exposure during Gestation: A Pharmacokinetic Virtual Clinical Trials Study. Metabolites 12:12, pages 1281.
Crossref
Crossref
Michael Zastrozhin, Valentin Skryabin, Valeriy Smirnov, Anastasiya Zastrozhina, Elena Grishina, Kristina Ryzhikova, Irina Bure, Pavel Golovinskii, Sergey Koporov, Evgeniy Bryun & Dmitry Sychev. (2022) Effect of Genetic Polymorphism of the CYP2D6 Gene on the Efficacy and Safety of Fluvoxamine in Major Depressive Disorder. American Journal of Therapeutics 29:1, pages e26-e33.
Crossref
Crossref
Gianluca Catucci, Gianfranco Gilardi & Sheila J. Sadeghi. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
509
562
.
Li Di, Amanda Balesano, Samantha Jordan & Sophia M. Shi. (2021) The Role of Alcohol Dehydrogenase in Drug Metabolism: Beyond Ethanol Oxidation. The AAPS Journal 23:1.
Crossref
Crossref
Yoichi Tanikawa, Mihoko Hagiwara-Nagasawa, Ryuichi Kambayashi, Ai Goto, Koki Chiba, Kumiko Kitta, Kiyotaka Hoshiai, Hiroko Izumi-Nakaseko, Atsuhiko T. Naito & Atsushi Sugiyama. (2019) Characterization of microminipig as a laboratory animal for safety pharmacology study by analyzing fluvoxamine-induced cardiovascular and dermatological adverse reactions. Cardiovascular Toxicology 19:5, pages 412-421.
Crossref
Crossref
Marc Augustin, Georgios Schoretsanitis, Philippe Pfeifer, Gerhard Gründer, Claus Liebe & Michael Paulzen. (2019) Effect of fluvoxamine augmentation and smoking on clozapine serum concentrations. Schizophrenia Research 210, pages 143-148.
Crossref
Crossref
Hui Li, Erica Toth & Nathan J Cherrington. (2018) Alcohol Metabolism in the Progression of Human Nonalcoholic Steatohepatitis. Toxicological Sciences 164:2, pages 428-438.
Crossref
Crossref
Vincent A. de Weger, Sanjay Goel, Roger von Moos, Jan H. M. Schellens, Nicholas Mach, Eugene Tan, Suraj Anand, Jeffrey W. Scott & Ulrik Lassen. (2017) A drug–drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology 81:1, pages 73-80.
Crossref
Crossref
Saeed Alqahtani & Amal Kaddoumi. (2016) Development of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model to Predict the Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics Represented by Receptor/Transporter Occupancy of Central Nervous System Drugs. Clinical Pharmacokinetics 55:8, pages 957-969.
Crossref
Crossref
Lingtak-Neander Chan & Gail D. Anderson. (2014) Pharmacokinetic and Pharmacodynamic Drug Interactions with Ethanol (Alcohol). Clinical Pharmacokinetics 53:12, pages 1115-1136.
Crossref
Crossref
Xingxing Diao. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics
1
4
.
Xingxing Diao. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics
1
5
.
Xingxing Diao, Pan Deng, Cen Xie, Xiuli Li, Dafang Zhong, Yifan Zhang & Xiaoyan Chen. (2013)
Metabolism and Pharmacokinetics of 3-
n
-Butylphthalide (NBP) in Humans: The Role of Cytochrome P450s and Alcohol Dehydrogenase in Biotransformation
. Drug Metabolism and Disposition 41:2, pages 430-444.
Crossref
Crossref
Yumiko Akamine, Norio Yasui-Furukori, Ichiro Ieiri & Tsukasa Uno. (2012) Psychotropic Drug–Drug Interactions Involving P-Glycoprotein. CNS Drugs 26:11, pages 959-973.
Crossref
Crossref
J. L. Pilgrim, D. Gerostamoulos & Olaf H. Drummer. (2010) Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Science, Medicine, and Pathology 7:2, pages 162-184.
Crossref
Crossref
Yasuhiro Katoh, Shinya Uchida, Masayoshi Kawai, Noriyoshi Takei, Norio Mori, Junichi Kawakami, Yoshiyuki Kagawa, Shizuo Yamada, Noriyuki Namiki & Hisakuni Hashimoto. (2010) Effects of Cigarette Smoking and Cytochrome P450 2D6 Genotype on Fluvoxamine Concentration in Plasma of Japanese Patients. Biological & Pharmaceutical Bulletin 33:2, pages 285-288.
Crossref
Crossref